Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others

Fig. 1

Analysis of the proportion of HSPC populations of CD34+ cells from the ilium or femur. A, B Proportion of each population, before culture, as a percentage (mean ± SD) of the CD34+ cells. CMP: common myeloid progenitor, GMP: granulocyte monocyte progenitor, MEP: megakaryocyte erythrocyte progenitor, MPP: multipotent progenitor, HSC: hematopoietic stem cell. C Proportion of early progenitors and myeloid progenitors after 7 days of culture in stem cell differentiation medium (mean percentage ± SD). D Number of cells (mean ± SD) after 7 days of culture of 1 × 104 CD34+ cells. E Number (mean ± SD) of different myeloid colonies after 14 days of culture in complete methylcellulose medium. GM granulocyte/monocyte, CFU-E colony forming unit erythrocyte, GEMM granulocyte/erythrocyte/monocyte/megakaryocyte, BFU-E burst forming unit erythrocyte. F Number of colonies (mean ± SD) obtained after Long-Term Culture Initiating Cell (LTC IC) assay per 1000 CD34+ cells

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512